Skip to content

Treatment of Cutaneous Ulcers With a Novel Biological Dressing

Treatment of Cutaneous Ulcers With a Novel Biological Dressing

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00207818
Enrollment
6
Registered
2005-09-21
Start date
1999-09-30
Completion date
2009-06-30
Last updated
2014-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Venous Ulcers

Keywords

tissue engineered wound dressing; autologous skin substitute; biological dressing; wound care

Brief summary

The aim of the study is to evaluate the effect of a biological dressing on the healing process of venous ulcers. The dressing is a reconstructed skin substitute made with the patients own cells.

Detailed description

The hypothesis of this trial is that the cutaneous model SASS, a dermal epidermal skin substitute, created by the LOEX could be as high-performant, or even better, than the one's already existent in North America for the wound care. We anticipate showing on 6 patients that ulcer that did not close with conventional treatment, will heal or at least improve with this treatment.

Interventions

Wound care with self assembled skin substitute (SASS)

Sponsors

CHU de Quebec-Universite Laval
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

1. Men or women from 18 to 85 years old 2. Have a venous ulcer or a mixed ulcer

Exclusion criteria

Diabetes Mental deficiency Hepatitis holder (A-B-C) HIV positive Pregnancy or lactation Corticosteroids therapy Radiotherapy Chemotherapy

Design outcomes

Primary

MeasureTime frame
wound closure

Secondary

MeasureTime frame
% of healing at 6 months of treatment

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026